PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 50 filers reported holding PASSAGE BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,061 | -30.3% | 27,449 | -0.3% | 0.00% | – |
| Q2 2023 | $25,904 | -1.7% | 27,519 | -0.0% | 0.00% | – |
| Q1 2023 | $26,362 | -33.4% | 27,526 | -4.1% | 0.00% | – |
| Q4 2022 | $39,595 | -51.7% | 28,692 | -56.4% | 0.00% | – |
| Q3 2022 | $82,000 | -66.1% | 65,834 | -35.7% | 0.00% | – |
| Q2 2022 | $242,000 | -47.2% | 102,328 | -30.6% | 0.00% | – |
| Q1 2022 | $458,000 | -47.7% | 147,545 | +7.1% | 0.00% | – |
| Q4 2021 | $875,000 | -27.0% | 137,737 | +14.5% | 0.00% | – |
| Q3 2021 | $1,198,000 | -5.1% | 120,270 | +26.2% | 0.00% | – |
| Q2 2021 | $1,262,000 | -5.5% | 95,322 | +24.7% | 0.00% | – |
| Q1 2021 | $1,336,000 | -45.9% | 76,418 | -20.9% | 0.00% | -100.0% |
| Q4 2020 | $2,469,000 | +1185.9% | 96,556 | +557.7% | 0.00% | – |
| Q3 2020 | $192,000 | -90.1% | 14,680 | -88.1% | 0.00% | -100.0% |
| Q1 2020 | $1,940,000 | – | 123,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $4,668,631 | 5.54% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $2,348,047 | 2.02% |
| BML Capital Management, LLC | 2,058,767 | $1,937,917 | 1.74% |
| Lynx1 Capital Management LP | 1,167,343 | $1,098,820 | 0.72% |
| Acuitas Investments, LLC | 418,173 | $393,626 | 0.23% |
| Orbimed Advisors | 10,124,576 | $9,530,263 | 0.17% |
| Frazier Life Sciences Management, L.P. | 1,850,000 | $1,741,405 | 0.10% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $282,390 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $80,999 | 0.02% |
| Annandale Capital, LLC | 54,338 | $51 | 0.02% |